Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Email us and we'll send you the joining details.
Inflammatory bowel disease presentation and diagnosis
Your doctor must submit a prior authorization request attesting that you met one of the following criteria: Pathway 1: BMI of 35 or higher at the time GLP-1 therapy was initiated (no additional conditions required) Pathway 2: BMI of 30 or higher, plus a diagnosis of heart failure with preserved ejection fraction, uncontrolled hypertension (systolic blood pressure above 140 mm Hg), or chronic kidney disease stage 3a or higher Pathway 3: BMI of 27 or higher, plus a diagnosis of pre-diabetes (per American Diabetes Association guidelines), a previous heart attack, a previous stroke, or symptomatic peripheral artery disease The medication must also be prescribed in combination with ongoing lifestyle modification, including structured nutrition and physical activity guidance consistent with the FDA-approved drug label
For optimal health, blood sugars should stay in a target range (not too low or too high)
and the inability to experience joy or pleasure, known as anhedonia
For a comprehensive walkthrough of injection technique with visual references, the peptide injection guide provides additional detail
